Lung Cancer in Republic of China

Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial

(2020) Harry J. de Koning et al.   NEW ENGLAND JOURNAL OF MEDICINE

Tepotinib in Non–Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations

(2020) Paul K. Paik et al.   NEW ENGLAND JOURNAL OF MEDICINE

The overview and prospects of BNCT facility at Tsing Hua Open-pool reactor

(2020) Shiang-Huei Jiang et al.   APPLIED RADIATION AND ISOTOPES

Computed tomography-guided dual localization with microcoil and patent blue vital dye for deep-seated pulmonary nodules in thoracoscopic surgery

(2019) Chi-Wei Lin et al.   JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION

Phase I study of capmatinib in MET‐positive solid tumor patients: dose escalation and expansion of selected cohorts

(2019) Yung‐Jue Bang et al.   CANCER SCIENCE

Radial endobronchial ultrasound-guided transbronchial biopsy for peripheral pulmonary malignancy: biopsy- or brushing-first?

(2019) Chun-Ta Huang et al.   BMC Pulmonary Medicine

Electromagnetic navigation-guided versus computed tomography-guided percutaneous localization of small lung nodules before uniportal video-assisted thoracoscopic surgery: a propensity score-matched analysis

(2019) Chia-Tsung Hung et al.   EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY

Feasibility and Safety of Pleuroscopic Cryobiopsy of the Pleura: A Prospective Study

(2018) Chia-Hung Chen et al.   Canadian Respiratory Journal

Phase II Study of Crizotinib in East Asian Patients With ROS1-Positive Advanced Non–Small-Cell Lung Cancer

(2018) Yi-Long Wu et al.   JOURNAL OF CLINICAL ONCOLOGY

Tubeless single-port thoracoscopic sublobar resection: indication and safety

(2018) Chao-Yu Liu et al.   Journal of Thoracic Disease

Brigatinib versus Crizotinib in ALK-Positive Non–Small-Cell Lung Cancer

(2018) D. Ross Camidge et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pan-Asian adapted Clinical Practice Guidelines for the management of patients with metastatic non-small cell lung cancer; a CSCO-ESMO initiative endorsed by JSMO, KSMO, MOS, SSO and TOS

(2018) Y -L Wu et al.   ANNALS OF ONCOLOGY

The feasibility of electromagnetic navigation–guided percutaneous microcoil localization for thoracoscopic resection of small pulmonary nodules

(2018) Po-Kuei Hsu et al.   JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY

Lorlatinib in patients with ALK-positive non-small-cell lung cancer: results from a global phase 2 study

(2018) Benjamin J Solomon et al.   LANCET ONCOLOGY

Pooled Systemic Efficacy and Safety Data from the Pivotal Phase II Studies (NP28673 and NP28761) of Alectinib in ALK -positive Non-Small Cell Lung Cancer

(2017) James Chih-Hsin Yang et al.   Journal of Thoracic Oncology

First-line ceritinib versus platinum-based chemotherapy in advanced ALK -rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study

(2017) Jean-Charles Soria et al.   LANCET

The safety and efficacy of alfentanil-based induction in bronchoscopy sedation

(2016) Chung-Hsing Hsieh et al.   MEDICINE

AZD9291 in EGFR Inhibitor–Resistant Non–Small-Cell Lung Cancer

(2015) Pasi A. Jänne et al.   NEW ENGLAND JOURNAL OF MEDICINE

Role of Flexible Bronchoscopic Cryotechnology in Diagnosing Endobronchial Masses

(2013) Chun-Liang Chou et al.   ANNALS OF THORACIC SURGERY

Afatinib for patients with lung adenocarcinoma and epidermal growth factor receptor mutations (LUX-Lung 2): a phase 2 trial

(2012) James Chih-Hsin Yang et al.   LANCET ONCOLOGY

Nonintubated Thoracoscopic Lobectomy for Lung Cancer

(2011) Jin-Shing Chen et al.   ANNALS OF SURGERY

Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening

(2011)   NEW ENGLAND JOURNAL OF MEDICINE

Diagnostic Value of EBUS-TBNA for Lung Cancer with Non-Enlarged Lymph Nodes: A Study in a Tuberculosis-Endemic Country

(2011) Chih-Hsi Kuo et al.   PLoS One

Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma

(2009) Tony S. Mok et al.   NEW ENGLAND JOURNAL OF MEDICINE